The prevalence and spectrum of mucocutaneous disease in South African people living with HIV and accessing care at a district-level hospital
Open Access
- 16 January 2020
- journal article
- research article
- Published by AOSIS in Southern African Journal of HIV Medicine
- Vol. 21 (1)
Abstract
Background: Although the association between human immunodeficiency virus (HIV) and mucocutaneous diseases has been well studied within South African specialist centres, there is limited data from district-level hospitals. Available data may, therefore, fail to reflect the prevalence and full spectrum of dermatoses seen in people living with HIV (PLWH).Objectives: To determine the prevalence and spectrum of dermatoses seen in PLWH.Method: We conducted a cross-sectional, descriptive study of 970 PLWH (men and women, ≥ 18 years old) accessing care at Karl Bremer Hospital, a district-level hospital located in the Western Cape province, South Africa, between 01 September 2016 and 28 February 2017.Results: The prevalence of mucocutaneous disease in this sample was 12.7% (95% confidence interval [CI] 0.11–0.15). Non-infectious dermatoses comprised 71.0% of the disorders. Pruritic papular eruption (20.0%) and seborrheic dermatitis (6.0%) were the most common non-infectious dermatoses. Tinea corporis (8.0%) and oral candidiasis (6.0%) were the most prevalent infectious dermatoses. There was no significant association between skin disease category (infectious or non-infectious dermatoses) and patient demographics (gender and ethnicity) or HIV-disease characteristics (CD4+ cell count, viral load and duration of antiretroviral therapy [ART]).Conclusion: This study provides valuable scientific data on the prevalence and spectrum of mucocutaneous disease in PLWH attending a South African district-level hospital. Prospective studies conducted in other district-level centres across the country are required to determine the lifetime prevalence and spectrum of dermatoses in PLWH in the ART era.Keywords
This publication has 29 references indexed in Scilit:
- Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort StudiesPLOS Medicine, 2013
- Mucocutaneous manifestations of HIV‐infected patients in the era of HAART in Guangxi Zhuang Autonomous Region, ChinaJournal of the European Academy of Dermatology and Venereology, 2012
- New insights into HIV‐1‐primary skin disordersJournal of the International AIDS Society, 2011
- Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort studyThe Lancet Oncology, 2009
- Spectrum of skin disorders in human immunodeficiency virus‐infected patients in Singapore and the relationship to CD4 lymphocyte countsInternational Journal of Dermatology, 2007
- Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: An institutional urban clinic experienceJournal of the American Academy of Dermatology, 2006
- Cutaneous manifestations of HIV in Kwa‐Zulu Natal, South AfricaInternational Journal of Dermatology, 2006
- The impact of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) on skin disease in KwaZulu‐Natal, South AfricaInternational Journal of Dermatology, 2004
- Pruritic papular eruption in HIV seropositive patients: a cutaneous marker for immunosuppressionInternational Journal of Dermatology, 1999
- HIV-related skin diseasesThe Lancet, 1996